
Rauwolfia Serpentina

Rauwolfia Serpentina
Purity Levels
Reserpine 95%
Rauwolfia serpentina (Indian snakeroot) root is the source of reserpine, a well-documented indole alkaloid and historically one of the first natural antihypertensive pharmaceuticals ever isolated. Mechotech designs and manufactures turnkey extraction plants that process the root into a standardised extract, declared to Reserpine 95% by HPLC assay, for pharmaceutical and standardised-alkaloid ingredient supply. Because reserpine is a pharmacologically active alkaloid, buyers should confirm the current regulatory classification for their target market and application before commercial use — reserpine-containing products may carry prescription or pharma-grade regulatory requirements in various jurisdictions.
Mechotech's Rauwolfia serpentina plant is engineered around the chemistry of reserpine and related indole alkaloids concentrated in the root, using solvent extraction, acid-base purification and crystallisation to isolate and standardise the alkaloid fraction to a declared HPLC specification. Reserpine occurs in the root alongside a range of other minor Rauwolfia alkaloids (including ajmaline and yohimbine-type compounds), so the purification train is specifically tuned to selectively concentrate reserpine rather than the total alkaloid pool, which is why the route targets a single-compound specification such as the catalogue’s Reserpine 95% rather than a broad total-alkaloid percentage. Built in SS 316L with integrated solvent recovery, automation, and full documentation, each plant is delivered as a commissioned turnkey system configured to the client’s target specification (the catalogue lists Reserpine 95%), with the specification achieved established during process development and pilot validation. As with other alkaloid-class actives, regulatory handling of reserpine varies by market and end-use — this is stated factually here, not as a medical claim, and buyers are responsible for confirming compliance for their specific application.
Technical Specifications
| Product | Rauwolfia Serpentina Extraction Plant |
|---|---|
| Botanical Name | Rauwolfia serpentina |
| Raw Material | Dried Rauwolfia serpentina root |
| Plant Part | Root |
| Key Active | Reserpine (indole alkaloid), one of the first isolated natural antihypertensive pharmaceuticals |
| Standardisation | Reserpine 95% by HPLC |
| Extraction Method | Solvent extraction (alcohol/hydro-alcoholic) with acid-base purification, closed jacketed SS 316L extractors |
| Purification Method | Acid-base partition and crystallisation to isolate the alkaloid fraction |
| Product-contact Material | SS 316L, electropolished, CIP-cleanable |
| Filtration System | Plate-and-frame filter press with cartridge polish filtration |
| Concentration System | Falling-film / vacuum evaporator with closed-loop solvent recovery |
| Drying System | Vacuum tray dryer or spray dryer |
| Automation | PLC-SCADA with recipe management, batch traceability and production reporting |
| Plant Capacity | Configured to requirement |
| Utility Requirements | Steam, chilled/cooling water, compressed air, soft water, power (project-specific) |
| Compliance | GMP hygienic design; full documentation for qualification. Reserpine-containing products may carry prescription/pharma-grade regulatory requirements — buyers should confirm current classification for their target market and application. |
| Final Product Form | Free-flowing standardised alkaloid extract powder |
Plant Capacities
| Plant Scale | Root Throughput | Typical Use |
|---|---|---|
| Pilot | Configured to your feedstock and trial plan | Product development, alkaloid-recovery validation |
| Semi-Commercial | Configured between pilot and commercial scale | Contract manufacturing, scale-up trials |
| Commercial | Configured to raw-material supply and confirmed buyer volume | Export-grade continuous production |
Capacity is configured to raw-material supply and confirmed buyer volume; we recommend a pilot plant to validate reserpine recovery and purification parameters before scaling.
Manufacturing Process
Raw Material Preparation
Dried Rauwolfia serpentina root is authenticated, tested for moisture, and milled to a uniform particle size to maximise solvent contact before extraction.
Solvent Extraction
Milled root is extracted with an alcohol or hydro-alcoholic solvent system in closed jacketed SS 316L extractors under controlled temperature and multiple cycles to maximise recovery of the total alkaloid fraction, including reserpine.
Acid-Base Purification
The crude extract is processed through acid-base partition steps that selectively isolate the indole alkaloid fraction from co-extracted plant matter, concentrating reserpine ahead of crystallisation.
Filtration
The purified extract is clarified through a plate-and-frame filter press followed by cartridge polish filters.
Concentration, Crystallisation & Solvent Recovery
The extract is concentrated in a falling-film / vacuum evaporator with closed-loop solvent recovery, then crystallised to isolate high-purity reserpine.
Standardisation
The isolated alkaloid is assayed by HPLC and adjusted to the declared Reserpine 95% specification before final drying.
Drying & Quality Control
The standardised extract is vacuum tray- or spray-dried, then released after assay, residual-solvent, heavy-metal, microbial, and moisture testing with full certificate of analysis.
Major Plant Equipment
- Raw material cleaning system
- Hammer mill (size reduction)
- Stainless-steel jacketed extraction vessels (SS 316L)
- Acid-base purification / partition system
- Plate-and-frame filter press / cartridge polish filters
- Falling-film / vacuum evaporator
- Crystallisation unit
- Closed-loop solvent recovery system
- Vacuum tray dryer / spray dryer
- CIP (clean-in-place) system
- Storage tanks & finished-product handling
- PLC-SCADA control panel, electrical MCC & instrumentation
Plant Output
Applications
- Pharmaceutical standardised alkaloid ingredient supply (subject to market-specific regulatory classification)
- Standardised extract supply for research and formulation development
- Ayurvedic and traditional medicine preparations (Sarpagandha formulations, where locally permitted)
- Export to regulated-market pharmaceutical ingredient buyers
Key Features
GMP Hygienic SS 316L Construction
Electropolished SS 316L product-contact surfaces use GMP hygienic design, with CIP operation between batches.
Dedicated Alkaloid Purification Train
Acid-base partition and crystallisation stages selectively isolate the indole alkaloid fraction, engineered specifically for reserpine recovery from root material.
Closed-Loop Solvent Recovery
Integrated recovery returns solvent for reuse each batch, reducing fresh-solvent consumption.
Standardised to Reserpine 95%
In-process and batch-release HPLC assay are used to check the finished extract against its declared Reserpine 95% specification.
Regulatory-Aware Documentation
Full batch traceability and certificate-of-analysis documentation support buyers in confirming compliance for their target market's alkaloid/pharma regulatory classification.
Scalable Batch Capacity
Plants are configured to requirement from pilot scale upward, with modular expansion.
Frequently Asked Questions
Does Mechotech supply the complete machinery for Rauwolfia serpentina extraction?
What specification can the Rauwolfia serpentina plant achieve?
What is reserpine and why is it significant?
Are there regulatory considerations specific to reserpine-containing products?
Why does Rauwolfia serpentina extraction include an acid-base purification stage?
What plant part of Rauwolfia serpentina is used, and why?
What production capacities are available for the Rauwolfia serpentina plant?
Which industries and buyers use the Rauwolfia serpentina plant?
How does Mechotech ensure batch-to-batch consistency for a high-value alkaloid like reserpine?
Ready to discuss your project?
Get a free quote and technical consultation from our engineering team.